Tags : Atomico

East of England

Healx secures £43.86 million Series B investment led by Atomico

Healx secures $56M in Series B financing, launches global accelerator programme for rare diseases Latest round of funding, led by Atomico, will be used to build a clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism Healx’s Rare Treatment Accelerator programme is a new initiative launched in […]Read More